login
login

Europe Daily Bulletin No. 8996

23 July 2005
Contents Publication in full By article 48 / 51
ECONOMIC INTERPENETRATION / (eu) biotechnology

Swiss labs ROCHE (CHF 29.5 bn turnover in 2004, workforce of 65,000 in 150 countries) has bought up GLYCART BIOTECHNOLOGY, a privately owned Swiss biotech company producing technology to enhance the efficacy of antibodies, for CHF 235 mil.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION